Raymie McFarland

Raymie McFarland is a seasoned healthcare executive with extensive experience in driving growth and innovation across multiple organizations. Currently serving as Chief Growth Officer at Lirio since January 2025, McFarland leverages behavioral science to enhance healthcare engagement through personalized communications. Previously, McFarland held the position of Chief Commercial Officer at Atropos Health, focusing on the application of real-world evidence in clinical decision-making. Other notable roles include Head of Sales at Noteworth and President & Chief Executive Officer at Monarch Medical Technologies. McFarland played a vital role at Glytec as Chief Innovation and Outcomes Officer and Vice President of Sales, contributing to strategic planning for clinical studies. As co-founder of Mantra Healthcare Solutions, Inc. and through a progressive tenure at sanofi-aventis in various sales and management capacities, McFarland has demonstrated a commitment to improving patient outcomes and enhancing sales initiatives. Academic credentials include a degree in Exercise Physiology from East Carolina University.